Table 2 Participant demographics, baseline clinical characteristics and pre-existing cardiovascular risk factors (Medical Record Review cohort only)
From: Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
|
N = 46 n (%) | |
|---|---|
| Demographics | |
| Female | 23 (50) |
| Married/de facto | 28 (61) |
| Country of birth (Australia) | 32 (70) |
| Private health insurance | 15 (33) |
| Mean age of cardiotoxicity diagnosis (years) | 58.5 |
| Baseline clinical characteristics (pre-existing risk factors) | |
| ≥ 1 risk factor | 41 (90) |
| ≥ 4 risk factors | 11 (24) |
| Diabetes (type 1 or 2) | 12 (26) |
| Hypertension | 22 (48) |
| Hypercholesterolemia | 14 (30) |
| Stroke | 1 (2) |
| Angina | 5 (11) |
| Arrhythmia (atrial fibrillation) | 6 (13) |
| Valvular disease | 1 (2) |
| Current−/ex-smoker | 19 (41) |
| Social drinker | 11 (24) |
| Overweight/obese | 18 (39) |
| Family history of cardiovascular disease | 11 (24) |
| Participants with four or more risk factors | 11 (24) |